Oncternal Therapeutics Inc (ONCT) — Cash Flow Reinvestment Rate
Latest as of March 2008:
0.02x
Oncternal Therapeutics Inc (ONCT) has a Cash Flow Reinvestment Rate of 0.02x as of March 2008, reinvesting $697.00K (capex $697.00K ) from operating cash flow of $28.70 Million. Check Oncternal Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
$697.00K
Capex + Investments
Operating Cash Flow
$28.70 Million
USD
Capital Expenditures
$697.00K
USD
Annual Cash Flow Reinvestment Rate for Oncternal Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Oncternal Therapeutics Inc. For live market cap and broader valuation context, see Oncternal Therapeutics Inc (ONCT) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow